Recombinant Human AHSG

Background

Fetuin-A, also known as alpha-2-HS-glycoprotein (AHSG), is a circulating glycoprotein primarily synthesized by the liver. It plays diverse roles in the body, including regulation of mineral metabolism, inhibition of pathological calcification, modulation of insulin signaling, and regulation of inflammation. Fetuin-A functions as an inhibitor of ectopic mineralization by forming soluble complexes with calcium and phosphate ions, preventing their precipitation in soft tissues. Additionally, fetuin-A interacts with various receptors and signaling pathways, influencing insulin sensitivity and glucose homeostasis. Dysregulation of fetuin-A levels has been implicated in metabolic disorders such as diabetes, cardiovascular disease, and chronic kidney disease. Understanding the molecular mechanisms underlying fetuin-A function provides insights into its roles in health and disease, offering potential therapeutic targets for metabolic and cardiovascular conditions. Ongoing research continues to elucidate the multifaceted functions of fetuin-A and its implications for human health